Q2 2025

Filed Aug 18, 2025 · 10-Q · 49 days after period end · 0000950170-25-109642

Q2 2025 · 10-Q

Revenue

$6.55K

−98.9% vs Q2 2024

Net Income

-$1.93M

N/M vs Q2 2024

EPS Diluted

-$40.72

N/M vs Q2 2024

Gross Profit$1,310−99.3%

Operating Income

Same quarter

Metric	Q2 2025	Q2 2024	Q2 2023	Q2 2022
Revenue	$6.55K	$618.85K	$622.81K	$454.00K
Net Income	-$1.93M	-$15.28M	-$4.30M	-$3.51M
EPS Diluted	-$40.72	-$16.16	-$0.12	-$0.10

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

HCW Biologics Inc. · CIK 1828673 · Engraved from SEC EDGAR